Information Provided By:
Fly News Breaks for September 18, 2018
ESRX, CI
Sep 18, 2018 | 07:41 EDT
Credit Suisse analyst A.J. Rice reiterated an Outperform rating on Cigna (CI) and raised his price target to $237 after the DOJ approved Cigna's acquisition of Express Scripts (ESRX). In a research note to investors, Rice says that while he sees Cigna shares trading at a discount to other MCOs given its business mix, he expects the discount to narrow by at least 2x over the next 12 months.